BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 19925559)

  • 1. Activation of STAT3 and inhibitory effects of pioglitazone on STAT3 activity in a mouse model of SOD1-mutated amyotrophic lateral sclerosis.
    Shibata N; Yamamoto T; Hiroi A; Omi Y; Kato Y; Kobayashi M
    Neuropathology; 2010 Aug; 30(4):353-60. PubMed ID: 19925559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the PPARgamma activator pioglitazone on p38 MAP kinase and IkappaBalpha in the spinal cord of a transgenic mouse model of amyotrophic lateral sclerosis.
    Shibata N; Kawaguchi-Niida M; Yamamoto T; Toi S; Hirano A; Kobayashi M
    Neuropathology; 2008 Aug; 28(4):387-98. PubMed ID: 18312546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential activation of neuronal and glial STAT3 in the spinal cord of the SOD1
    Ohgomori T; Yamasaki R; Takeuchi H; Kadomatsu K; Kira JI; Jinno S
    Eur J Neurosci; 2017 Aug; 46(4):2001-2014. PubMed ID: 28715117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein-bound crotonaldehyde accumulates in the spinal cord of superoxide dismutase-1 mutation-associated familial amyotrophic lateral sclerosis and its transgenic mouse model.
    Shibata N; Kawaguchi M; Uchida K; Kakita A; Takahashi H; Nakano R; Fujimura H; Sakoda S; Ihara Y; Nobukuni K; Takehisa Y; Kuroda S; Kokubo Y; Kuzuhara S; Honma T; Mochizuki Y; Mizutani T; Yamada S; Toi S; Sasaki S; Iwata M; Hirano A; Yamamoto T; Kato Y; Sawada T; Kobayashi M
    Neuropathology; 2007 Feb; 27(1):49-61. PubMed ID: 17319283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of signal transducer and activator of transcription-3 in the spinal cord of sporadic amyotrophic lateral sclerosis patients.
    Shibata N; Kakita A; Takahashi H; Ihara Y; Nobukuni K; Fujimura H; Sakoda S; Sasaki S; Iwata M; Morikawa S; Hirano A; Kobayashi M
    Neurodegener Dis; 2009; 6(3):118-26. PubMed ID: 19372705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
    Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
    Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of metallothionein-I, a copper-regulating protein, attenuates intracellular copper dyshomeostasis and extends lifespan in a mouse model of amyotrophic lateral sclerosis caused by mutant superoxide dismutase-1.
    Tokuda E; Okawa E; Watanabe S; Ono S
    Hum Mol Genet; 2014 Mar; 23(5):1271-85. PubMed ID: 24163136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-6 Deficiency Does Not Affect Motor Neuron Disease Caused by Superoxide Dismutase 1 Mutation.
    Han Y; Ripley B; Serada S; Naka T; Fujimoto M
    PLoS One; 2016; 11(4):e0153399. PubMed ID: 27070121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effect of oxidized galectin-1 in a transgenic mouse model of amyotrophic lateral sclerosis.
    Chang-Hong R; Wada M; Koyama S; Kimura H; Arawaka S; Kawanami T; Kurita K; Kadoya T; Aoki M; Itoyama Y; Kato T
    Exp Neurol; 2005 Jul; 194(1):203-11. PubMed ID: 15899257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in the hypothalamic melanocortin pathway in amyotrophic lateral sclerosis.
    Vercruysse P; Sinniger J; El Oussini H; Scekic-Zahirovic J; Dieterlé S; Dengler R; Meyer T; Zierz S; Kassubek J; Fischer W; Dreyhaupt J; Grehl T; Hermann A; Grosskreutz J; Witting A; Van Den Bosch L; Spreux-Varoquaux O; ; Ludolph AC; Dupuis L
    Brain; 2016 Apr; 139(Pt 4):1106-22. PubMed ID: 26984187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered distribution and levels of cathepsinD and cystatins in amyotrophic lateral sclerosis transgenic mice: possible roles in motor neuron survival.
    Wootz H; Weber E; Korhonen L; Lindholm D
    Neuroscience; 2006 Dec; 143(2):419-30. PubMed ID: 16973300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues.
    Watanabe M; Dykes-Hoberg M; Culotta VC; Price DL; Wong PC; Rothstein JD
    Neurobiol Dis; 2001 Dec; 8(6):933-41. PubMed ID: 11741389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TDP-43 expression in mouse models of amyotrophic lateral sclerosis and spinal muscular atrophy.
    Turner BJ; Bäumer D; Parkinson NJ; Scaber J; Ansorge O; Talbot K
    BMC Neurosci; 2008 Oct; 9():104. PubMed ID: 18957104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of glial fibrillary acidic protein marginally accelerates disease progression in a SOD1(H46R) transgenic mouse model of ALS.
    Yoshii Y; Otomo A; Pan L; Ohtsuka M; Hadano S
    Neurosci Res; 2011 Jul; 70(3):321-9. PubMed ID: 21453731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DL-3-n-butylphthalide extends survival by attenuating glial activation in a mouse model of amyotrophic lateral sclerosis.
    Feng X; Peng Y; Liu M; Cui L
    Neuropharmacology; 2012 Feb; 62(2):1004-10. PubMed ID: 22056419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective formation of certain advanced glycation end products in spinal cord astrocytes of humans and mice with superoxide dismutase-1 mutation.
    Shibata N; Hirano A; Hedley-Whyte ET; Dal Canto MC; Nagai R; Uchida K; Horiuchi S; Kawaguchi M; Yamamoto T; Kobayashi M
    Acta Neuropathol; 2002 Aug; 104(2):171-8. PubMed ID: 12111360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NLRP3 inflammasome is expressed by astrocytes in the SOD1 mouse model of ALS and in human sporadic ALS patients.
    Johann S; Heitzer M; Kanagaratnam M; Goswami A; Rizo T; Weis J; Troost D; Beyer C
    Glia; 2015 Dec; 63(12):2260-73. PubMed ID: 26200799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redox system expression in the motor neurons in amyotrophic lateral sclerosis (ALS): immunohistochemical studies on sporadic ALS, superoxide dismutase 1 (SOD1)-mutated familial ALS, and SOD1-mutated ALS animal models.
    Kato S; Kato M; Abe Y; Matsumura T; Nishino T; Aoki M; Itoyama Y; Asayama K; Awaya A; Hirano A; Ohama E
    Acta Neuropathol; 2005 Aug; 110(2):101-12. PubMed ID: 15983830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bromocriptine methylate suppresses glial inflammation and moderates disease progression in a mouse model of amyotrophic lateral sclerosis.
    Tanaka K; Kanno T; Yanagisawa Y; Yasutake K; Hadano S; Yoshii F; Ikeda JE
    Exp Neurol; 2011 Nov; 232(1):41-52. PubMed ID: 21867702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuregulin 1 confers neuroprotection in SOD1-linked amyotrophic lateral sclerosis mice via restoration of C-boutons of spinal motor neurons.
    Lasiene J; Komine O; Fujimori-Tonou N; Powers B; Endo F; Watanabe S; Shijie J; Ravits J; Horner P; Misawa H; Yamanaka K
    Acta Neuropathol Commun; 2016 Feb; 4():15. PubMed ID: 26891847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.